Back to results
US 2010/0304360 A1Published application
Gold nanoparticle hpv genotyping system and assay
AssigneeNanosphere, Inc.
InventorsPeter Riccelli, Feng Sun
Life of this patent
Estimating the term…
Abstract
The invention provides oligonucleotides, kits and methods for genotyping HPV.
Claims19
A method for detecting high risk human papilloma virus (HPV) in a sample, comprising:
- a) providing a substrate having a capture probe bound thereto, wherein at least a portion of the capture probe has a nucleic acid sequence that is complementary to at least a first portion of the genome of a HPV;
- b) providing a mediator probe, wherein at least a portion of the mediator probe has a nucleic acid sequence that is complementary to at least a second portion of the HPV genome that is different than the first portion and a nucleotide sequence that is complementary to a non-HPV sequence on oligonucleotides bound to a gold particle, wherein the nucleic acid sequence in the capture probe or the mediator probe, or both, are HPV-subtype specific;
- c) contacting a sample suspected of having HPV that is subjected to an amplification reaction with HPV-specific primers, the substrate, the mediator probe and gold particles having oligonucleotides with sequences that are complementary to the nucleotide sequence in the mediator probe under conditions that are effective for the hybridization of the nucleic acid sequence in the capture probe and the nucleic acid sequence in the mediator probe to amplified HPV DNA in the sample and for the hybridization of the nucleotide sequence in the mediator probe to the oligonucleotides bound to the gold particle;
- d) washing the substrate to remove non-specifically bound material;
- and
- e) detecting whether gold particles are bound to the substrate, wherein binding of gold particles to the substrate is indicative of the presence of a specific subtype of HPV in the sample.
3 more elements
A kit comprising at least two of:
- a) a capture probe, at least a portion of which has a nucleic acid sequence that complementary to at least a first portion of a genome of a HPV;
- b) a mediator probe, at least a portion of which has a nucleic acid sequence that is complementary to at least a second portion of the genome of the HPV that is different than the first portion and a nucleotide sequence that is complementary to a non-HPV sequence on oligonucleotides bound to a gold particle;
- or
- c) gold particles having the oligonucleotides;
- wherein the nucleic acid sequence in the capture probe or the mediator probe has SEQ ID No. 8-31, 38-55, 63-78, 83-98, 103-115, 119-135, 144-161, 168-181, 186-199, 207-230, 239-254, 259-267, or 276-313, or a sequence with at least 90% nucleotide sequence identity thereto.
2 more elements
An isolated oligonucleotide comprising one of SEQ ID Nos. 1-313, a sequence with at least 80% sequence identity thereto, the complement of one of SEQ ID No. 1-313 or the sequence with 80% sequence identity thereto, or a fragment thereof with at least 10 contiguous nucleotides.
Dependencies are inferred from the claim text.